CD19 CAR-T cell treatment conferred sustained remission in B-ALL patients with minimal residual diseaseWenyi Lu, Mingfeng Zhao, Qing Li et al.|Cancer Immunology Immunotherapy|2021Cited by 22
CD19 CAR-T Cells Treatment Conferred a Sustained Remission in Patients with Chemotherapy-Refractory MRD in B-ALLWenyi Lu, Mingfeng Zhao, Yunxiong Wei et al.|Blood|2020Cited by 0